(Q36136069)

12 August 2017

Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer (English)

1 reference

12 August 2017

Lehrer S

1

1 reference

12 August 2017

Terk M

2

1 reference

12 August 2017

Piccoli SP

3

1 reference

12 August 2017

Song HK

4

1 reference

12 August 2017

Lavagnini P

5

1 reference

12 August 2017

Luderer AA

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

6

1 reference

12 August 2017

871-873

1 reference

Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Detection of hematogenous micrometastasis in patients with prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074722

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction

23 September 2018

1 reference

12 December 2020

Breast cancer prognostic factors--the search goes on

1 reference

12 December 2020

Detection of prostate-specific antigen immunoreactivity in breast tumors

1 reference

12 December 2020

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications

1 reference

12 December 2020

New biological functions of prostate-specific antigen?

1 reference

12 December 2020

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.450

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8826851

1 reference